SCHEMBL128184

SCHEMBL128184

[CH2]c1cnc(C(=O)OCCC)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
LMNA P02545 3/20 0.42
ESR1 P03372 1/20 0.41
CHRM1 P11229 1/20 0.41
TSHR P16473 1/20 0.41
SLC6A2 P23975 1/20 0.41
KDR P35968 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 4/20 0.37
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL128676 0.86 CDC7 (0.48) ALDH1A1LMNATSHRMAPTGABRP
SCHEMBL128185 0.81 ALDH1A1 (0.44) ALDH1A1LMNAESR1CHRM1TSHR
SCHEMBL129390 0.81 ALDH1A1 (0.41) ALDH1A1LMNAESR1CHRM1TSHR
SCHEMBL130300 0.77 MAPK1 (0.43) ALDH1A1LMNATSHRL3MBTL1MAPT
SCHEMBL127432 0.72 CA12 (0.38) ALDH1A1LMNAMAPTNPC1RAB9A
SCHEMBL27915485 0.71 CDC7 (0.43) ALDH1A1LMNAESR1CHRM1TSHR
SCHEMBL28293724 0.71 LMNA (0.50) ALDH1A1LMNAESR1TSHRTDP1
SCHEMBL20267928 0.70 HCAR2 (0.53) ALDH1A1LMNAESR1CHRM1TSHR
SCHEMBL129713 0.70 LMNA (0.46) ALDH1A1LMNAESR1CHRM1TSHR
SCHEMBL12350737 0.69 MAPT (0.45) ALDH1A1LMNAESR1CHRM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450319-B2 Pyrrolopyridazinone compound UBE INDUSTRIES, LTD. (JP) 2013-05-28 US disclosed
EP-1982986-B1 PYRROLOPYRIDAZINONE COMPOUND AS PDE4 INHIBITOR UBE INDUSTRIES (JP) 2012-03-07 EP disclosed
US-20090036453-A1 Pyrrolopyridazinone Compound UBE INDUSTRIES, LTD. (JP) 2009-02-05 US disclosed
EP-1982986-A1 PYRROLOPYRIDAZINONE COMPOUND Ube Industries, Ltd. (JP) 2008-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036453-A1 Pyrrolopyridazinone Compound CBR3, CBR1, CYC1 ALDH1A1 580/4885LMNA 1679/4885ESR1 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.